Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 7
2007 9
2008 1
2009 2
2010 2
2011 3
2012 6
2013 6
2014 2
2015 3
2016 1
2017 7
2018 9
2019 8
2020 9
Text availability
Article attribute
Article type
Publication date

Search Results

60 results
Results by year
Filters applied: . Clear all
Page 1
The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis.
Amminger GP, Nelson B, Markulev C, Yuen HP, Schäfer MR, Berger M, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, McGorry PD. Amminger GP, et al. Among authors: mossaheb n. Biol Psychiatry. 2020 Feb 1;87(3):243-252. doi: 10.1016/j.biopsych.2019.08.030. Epub 2019 Sep 18. Biol Psychiatry. 2020. PMID: 31690495
Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis.
Alqarni A, Mitchell TW, McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Berger M, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Meyer BJ, Amminger GP. Alqarni A, et al. Among authors: mossaheb n. Schizophr Res. 2019 Oct 9:S0920-9964(19)30389-5. doi: 10.1016/j.schres.2019.08.033. Online ahead of print. Schizophr Res. 2019. PMID: 31606244
Fulminant Onset of Valproate-Associated Hyperammonemic Encephalopathy.
Baumgartner J, Hoeflich A, Hinterbuchinger B, Fellinger M, Graf I, Friedrich F, Frey R, Mossaheb N. Baumgartner J, et al. Among authors: mossaheb n. Am J Psychiatry. 2019 Nov 1;176(11):900-903. doi: 10.1176/appi.ajp.2019.18040363. Am J Psychiatry. 2019. PMID: 31672038 No abstract available.
Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial.
Berger M, Nelson B, Markulev C, Yuen HP, Schäfer MR, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Mitchell TW, Meyer BJ, Thompson A, Yung AR, McGorry PD, Amminger GP. Berger M, et al. Among authors: mossaheb n. Front Psychiatry. 2019 Jun 6;10:393. doi: 10.3389/fpsyt.2019.00393. eCollection 2019. Front Psychiatry. 2019. PMID: 31244693 Free PMC article.
The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.
McHugh MJ, McGorry PD, Yuen HP, Hickie IB, Thompson A, de Haan L, Mossaheb N, Smesny S, Lin A, Markulev C, Schloegelhofer M, Wood SJ, Nieman D, Hartmann JA, Nordentoft M, Schäfer M, Amminger GP, Yung A, Nelson B. McHugh MJ, et al. Among authors: mossaheb n. Schizophr Res. 2018 May;195:543-548. doi: 10.1016/j.schres.2017.09.003. Epub 2017 Oct 19. Schizophr Res. 2018. PMID: 29055567
Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial.
McGorry PD, Nelson B, Markulev C, Yuen HP, Schäfer MR, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger GE, Chen EY, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, Amminger GP. McGorry PD, et al. Among authors: mossaheb n. JAMA Psychiatry. 2017 Jan 1;74(1):19-27. doi: 10.1001/jamapsychiatry.2016.2902. JAMA Psychiatry. 2017. PMID: 27893018 Free article. Clinical Trial.
Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomes.
Youn S, Phillips LJ, Amminger GP, Berger G, Chen EYH, de Haan L, Hartmann JA, Hickie IB, Lavoie S, Markulev C, McGorry PD, Mossaheb N, Nieman DH, Nordentoft M, Riecher-Rössler A, Schäfer MR, Schlögelhofer M, Smesny S, Thompson A, Verma S, Yuen HP, Yung AR, Nelson B. Youn S, et al. Among authors: mossaheb n. Schizophr Res. 2020 Feb;216:255-261. doi: 10.1016/j.schres.2019.11.047. Epub 2019 Dec 19. Schizophr Res. 2020. PMID: 31866077
Dynamic prediction of transition to psychosis using joint modelling.
Yuen HP, Mackinnon A, Hartmann J, Amminger GP, Markulev C, Lavoie S, Schäfer MR, Polari A, Mossaheb N, Schlögelhofer M, Smesny S, Hickie IB, Berger G, Chen EYH, de Haan L, Nieman DH, Nordentoft M, Riecher-Rössler A, Verma S, Thompson A, Yung AR, McGorry PD, Nelson B. Yuen HP, et al. Among authors: mossaheb n. Schizophr Res. 2018 Dec;202:333-340. doi: 10.1016/j.schres.2018.07.002. Epub 2018 Jul 7. Schizophr Res. 2018. PMID: 30539771 Clinical Trial.
Psychotic-like experiences in esoterism: A twilight zone?
Hinterbuchinger B, Litvan Z, Meyer EL, Friedrich F, Kaltenboeck A, Gruber M, König D, Sueßenbacher S, Mossaheb N. Hinterbuchinger B, et al. Among authors: mossaheb n. Schizophr Res. 2018 Mar;193:240-243. doi: 10.1016/j.schres.2017.08.009. Epub 2017 Aug 18. Schizophr Res. 2018. PMID: 28826998
Polyunsaturated fatty acids in emerging psychosis.
Mossaheb N, Schloegelhofer M, Schaefer MR, Fusar-Poli P, Smesny S, McGorry P, Berger G, Amminger GP. Mossaheb N, et al. Curr Pharm Des. 2012;18(4):576-91. doi: 10.2174/138161212799316055. Curr Pharm Des. 2012. PMID: 22239591 Review.
60 results
Jump to page
Feedback